Smith Saxon D, Farrugia Lisa L, Harris Victoria, Lee Andrew, Carter Stephen R, Blaszczynski Alex, Fischer Gayle
a The Dermatology and Skin Cancer Centre , Gosford , New South Wales , Australia.
b Department of Dermatology , Royal North Shore Hospital , Sydney , New South Wales , Australia.
J Dermatolog Treat. 2017 Nov;28(7):642-646. doi: 10.1080/09546634.2017.1306017. Epub 2017 Apr 16.
Topical corticosteroids (TCS) are key to managing chronic inflammatory dermatoses (CID). Parents/patients cite TCS phobia as an impediment to treatment adherence. Family/friends and the Internet are a source of misinformation on TCS which can negatively impact perceptions of TCS safety.
To assess information from family/friends and the Internet, as related to and reported by patients/parents using long-term TCS.
A multicenter cross-sectional survey of patients (aged >18 years) and parents of patients (aged <18 years) with a history of CID requiring long-term (≥1 month) TCS use assessing messages about TCS received from family/friends and the Internet.
A total of 123 patients and 78 parents completed the survey (n = 201). Parents/patients were more likely to be informed by the Internet "[having] my [child's] skin condition means that [I/he/she] will need to use topical corticosteroids" (p < .001) and that "inflamed skin conditions will improve with the topical corticosteroids" (p = .007). Family/friends were more likely to recommend parents/patients "try non-prescription creams/ointments before resorting to the use of prescription topical corticosteroids" (p = .014).
High rates of messages about TCS "risk" from family/friends and the Internet may affect patient/parent understanding about TCS safety. This may contribute to treatment non-adherence.
外用糖皮质激素(TCS)是治疗慢性炎症性皮肤病(CID)的关键。家长/患者称对TCS的恐惧是治疗依从性的障碍。家人/朋友和互联网是关于TCS错误信息的来源,这可能会对TCS安全性的认知产生负面影响。
评估家人/朋友和互联网提供的、与长期使用TCS的患者/家长相关并由他们报告的信息。
对有CID病史且需要长期(≥1个月)使用TCS的患者(年龄>18岁)及其家长(年龄<18岁)进行多中心横断面调查,评估从家人/朋友和互联网收到的关于TCS的信息。
共有123名患者和78名家长完成了调查(n = 201)。家长/患者更有可能从互联网得知“[我的/孩子的]皮肤状况意味着[我/他/她]需要使用外用糖皮质激素”(p <.001)以及“外用糖皮质激素会改善皮肤炎症状况”(p =.007)。家人/朋友更有可能建议家长/患者“在使用处方外用糖皮质激素之前先尝试非处方乳膏/软膏”(p =.014)。
家人/朋友和互联网提供的关于TCS“风险”的信息比例较高,可能会影响患者/家长对TCS安全性的理解。这可能导致治疗不依从。